Prefilled Syringe

Product Description

Fill-finish syringe manufacturing is one of the last steps in pharmaceutical commercialization. The goal here is efficiency and sterility. Companies don’t want to waste any of their carefully developed product and they don’t want to distribute poor quality prefilled syringes or contaminated formulas. Once established, high syringe manufacturing standards must then be maintained throughout the drug’s life span, to deliver a reliable supply for patients.

With advanced fill-finish technology and a specialized facility in Barceloneta, Puerto Rico, AbbVie Contract Manufacturing performs this final development step with high-tuned efficiency. Aseptic filling is done within purpose-built machines that maximize product volumes, while decreasing contamination risk and human variables. For added security, AbbVie experts then undertake rigorous analytical screening and quality control. Through this, customers gain access to the world’s most advanced syringe manufacturing processes, people and facilities, with a global network geared towards security of supply.

PREFILLED SYRINGE CAPABILITIES AbbVie Contract Manufacturing offers a continuous workflow for a range of prefilled syringes, packaging and supply options, including:  Disposable syringe manufacturing, Safety syringes, Sterile injectables and Prefilled syringe packaging. 
ABBVIE ASEPTIC FILLING With the use of sophisticated fill finish techniques and equipment – including Restricted Access Barrier System (RABS) technology – AbbVie Contract Manufacturing brings total efficiency to the full syringe manufacturing workflow. Our competitive advantage comes through a combination of people, processes and tools, including:

An aseptic filling suite utilizing RABS technology, Filler utilizing peristaltic pump technology, Fill volumes from 0.4 mL – 8 mL (in BD Hypak or equivalent type syringe utilizing the SCF Format), 100% visual inspectionCompatible with closures packaged in rapid transfer port systemCold chain warehousing and On-site microbial laboratory, chemistry and testing.

AbbVie CMO

  • US
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
Specifications
  • Supplied from
    Puerto Rico; United States

AbbVie CMO

  • US
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical

More Products from AbbVie CMO (13)

  • Drug Product

    Product Drug Product

    Whether you’re developing a new chemical entity or a first-to-market generic, precise dosing and drug delivery is vital for success. Regulatory agencies and clinicians want to see well-characterized, reliable doses with good bioavailability. Patients/consumers often favor a controlled release dosage form, ...
  • Hot Melt Extrusion (HME)

    Product Hot Melt Extrusion (HME)

    Hot melt extrusion (HME) is a proven technology for bioavailability enhancement of poorly soluble API's. Unlike other formulation options, hot melt extrusion technology is solvent-free. By drawing on continuous processing, it is also more economical and can be used for abuse deference and taste masking app...
  • Fermentation

    Product Fermentation

    Fermentation is a critical step in both drug and toll manufacturing, as companies look to produce the core compounds that form their eventual products. While it is possible to undertake this in-house, the expertise contract fermentation services provide can improve the quality, affordability, speed and sca...
  • Biologics Development and Manufacturing

    Product Biologics Development and Manufacturing

    With patients’ lives at the end of the pipeline, biologics contract manufacturing needs to be safe, reliable and be consistent in supply. The developers of these large molecule drugs, however, are also operating in a highly competitive space. Speed-to-market is imperative, along with efficient processes an...
  • Antibody Drug Conjugates (ADC)

    Product Antibody Drug Conjugates (ADC)

    hen selecting AbbVie Contract Manufacturing, you are partnering with a leading developer and manufacturer focused on accelerating and mitigating risks to program timelines and on efficiently fast-tracking your program to completion. AbbVie’s mAb and ADC state-of-the-art facility and expert scientific team ...
  • Potent

    Product Potent

    High potency manufacturing is an expanding field with a unique set of challenges. Safety remains a primary concern for those handling cytotoxic drug products, as well as the clinicians and patients down the line. Beyond safety, pharmaceutical companies need to plan ahead for how they will manufacture high ...
  • Erythromycin Base

    Product Erythromycin Base

    For more information contact AbbVie Contract Manufacturing
  • Erythromycin Ethylsuccinate

    Product Erythromycin Ethylsuccinate

    For more information contact AbbVie Contract Manufacturing
  • Erythromycin Stearate

    Product Erythromycin Stearate

    For more information contact AbbVie Contract Manufacturing
  • Erythromycin Thiocyanate

    Product Erythromycin Thiocyanate

    For more information contact AbbVie Contract Manufacturing. 
  • Cyclosporine

    Product Cyclosporine

    For more information please contact AbbVie Contract Manufacturing. 
  • Aseptic Fill Finish

    Product Aseptic Fill Finish

    We offer two convenient fill-finish options for parenteral drug products: prefilled syringe and vials. As a leading pharmaceutical partner, we can provide all necessary elements of delivering high-quality parenteral products for clinical and commercial needs.

    AbbVie will leverage its know...

AbbVie CMO resources (2)

  • News AbbVie gains FDA approval for latest treatment for Parkinson's Disease

    AbbVie, the speciality biopharmaceutical company has once again made headway in the treatment of Parkinson’s disease. 
  • Brochure AbbVie CMO Services

    AbbVie’s Contract Manufacturing business has been serving our partners for more than 40 years. Our contract development and manufacturing capabilities span across 11 production facilities in North America and Europe. Our capabilities are: Aseptic Fill Finish (Vial and Prefilled Syringe) Custom & Bulk API Manufacturing Oral Solid Dose Fermentation Hot Melt Extrusion Potent Biologics Packaging